-
Product Insights
Childhood Epilepsy – Drugs In Development, 2023
Global Markets Direct’s, ‘Childhood Epilepsy - Drugs In Development, 2023’, provides an overview of the Childhood Epilepsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Childhood Epilepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Analyst Opinions
Tech, Genes, and Beyond – Startup Transforming Biotech
Biotech Startups Overview Biotech breakthroughs drive cost savings, provide competitive advantages, and showcase efficiency across industries through streamlined manufacturing, custom product development, and resilient supply chains. Biotech advancements are also reshaping the fields of medicine, agriculture, and industry. Startups are leading the way for biotechnology advancements, driven by healthcare demands, government support, and technological breakthroughs. Furthermore, AI integration is driving progress in DNA sequencing, drug discovery, and precision medicine. Meanwhile, ambitious projects such as longevity research and brain-computer interface implants...
-
Case Studies
New Product Development Opportunities from the Rise of Solo Households
New Product Development Opportunities from the Rise of Solo Households Report Overview Rapid urbanization and economic migration are the key factors responsible for the increase in the rates of solo living across the globe. Individuals often migrate from rural to urban areas as a necessity for higher income opportunities, which often requires a change in living arrangements, such as solo housing. Also, higher rates of urbanization can be viewed as a proxy for wealth and greater economic opportunity in some...
-
Company Insights
American Express (Amex) – Digital Transformation Strategies
American Express Digital Transformation Strategies Report Overview American Express is leveraging emerging technologies as a part of its digital transformation strategies. The annual ICT spending of American Express was estimated at $2.4 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. American Express (Amex) is a provider of card products and travel-related services. It offers a range of credit cards, charge cards, and other payment and financing solutions to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BL-001 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BL-001 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BL-001 in EpilepsyDrug Details:BL-001 is under development for the treatment of epilepsy, Dravet Syndrome and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BL-001 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BL-001 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BL-001 in Amyotrophic Lateral SclerosisDrug Details:BL-001 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3537021 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3537021 in Type 2 Diabetes report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...
-
Sector Analysis
Australia Hydrogen Market Size and Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Australia Hydrogen Market Report Overview Australia’s active hydrogen production capacity is 10.2ktpa which is less than 1% of global active capacity. However, the country’s wind and solar resources combined with the falling cost of producing renewable energy will greatly increase the opportunities for low-carbon hydrogen production. As a result, it has one of the largest pipeline capacities for green hydrogen, making the country an early adopter within the market. Furthermore, Australia’s hydrogen market will benefit from policies at both the...